Diabetes Mellitus (AACE) (free)

AACE Diabetes Mellitus Comprehensive Care

AACE GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/71358

Contents of this Issue

Navigation

Page 26 of 27

Comments Administer with or without food. Replacing rosiglitazone and metformin taken separately as combination therapy, or if uncontrolled on rosiglitazone or metformin alone. Administer in divided doses with meals to reduce GI side effects associated with metformin. Replacing rosiglitazone and SU taken separately as combination therapy, or if uncontrolled on rosiglitazone or SU alone. Administer with first meal of the day. Table 13. Summary of Insulin Regimens Insulin Regimen Basal Premixed Prandial/ mealtime Basal-bolus (multiple daily injections) Continuous subcutaneous insulin infusion Components and Frequency of Administration Levemir® Lantus® (daily or twice a day) (once daily) NovoLog® (usually twice a day; occasionally used daily or 3 times a day) Apidra® Apidra® combination with detemir or glargine (daily) Apidra® , NovoLog® , NovoLog® , NovoLog® Mix 70/30 or Humalog® , or Humalog® , or Humalog® , or Humalog® Insulin Time-action Profiles Rapid (aspart, glulisine, lispro) Short (Regular) Intermediate [NPH] Basal (detemir or glargine) Mix 75/25™ (with meals) (with meals) in Injections per Day 1 or 2 1 2 3 4 Continuous Causes or exacerbates CHF in some patients. If signs and symptoms of CHF develop, treat accordingly and discontinue TZD. Contraindicated in NYHA Class III or IV CHF. Administration in patients receiving insulin or nitrates is not recommended. 0 2 4 6 8 10 12 14 16 Time (hours) 18 20 25 Relative Insulin Effect

Articles in this issue

Archives of this issue

view archives of Diabetes Mellitus (AACE) (free) - AACE Diabetes Mellitus Comprehensive Care